Supernus Pharmaceuticals
SUPN
#4169
Rank
$2.64 B
Marketcap
$46.16
Share price
1.63%
Change (1 day)
25.64%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Total assets

Total assets on the balance sheet as of September 2025 : $1.41 Billion USD

According to Supernus Pharmaceuticals 's latest financial reports the company's total assets are $1.41 Billion USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Supernus Pharmaceuticals - Total assets on balance sheet (from 2009 to 2025)

Total assets by year

Year Total assets Change
2024-12-31$1.36 B7.08%
2023-12-31$1.27 B-24.95%
2022-12-31$1.70 B0.79%
2021-12-31$1.68 B12.3%
2020-12-31$1.50 B29.63%
2019-12-31$1.16 B18.66%
2018-12-31$0.97 B130.36%
2017-12-31$0.42 B37.11%
2016-12-31$0.30 B64.12%
2015-12-31$0.18 B37.9%
2014-12-31$0.13 B23.23%
2013-12-31$0.11 B18.09%
2012-12-31$93.98 M74.93%
2011-12-31$53.73 M14.3%
2010-12-31$47 M-41.16%
2009-12-31$79.89 M3.59%
2008-12-31$77.13 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Zogenix
ZGNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
$7.35 B 417.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$114.93 B 7,995.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$96.88 B 6,724.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$84.18 B 5,829.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$192.81 B 13,480.98%๐Ÿ‡บ๐Ÿ‡ธ USA